scispace - formally typeset
E

Elika Verma

Researcher at Indian Institutes of Technology

Publications -  8
Citations -  87

Elika Verma is an academic researcher from Indian Institutes of Technology. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 3, co-authored 5 publications receiving 10 citations. Previous affiliations of Elika Verma include Indian Institute of Technology Guwahati.

Papers
More filters
Journal ArticleDOI

Long noncoding RNAs in triple-negative breast cancer: A new frontier in the regulation of tumorigenesis.

TL;DR: In this paper, a review highlights the association of several lncRNAs in TNBC progression and treatment, along with their possible functions and mechanisms, and extensive research is being carried out to reveal it.
Journal ArticleDOI

Xanthohumol from Hop: Hope for Cancer Prevention and Treatment.

TL;DR: In this paper, a review of the literature on the anti-cancer properties of Xanthohumol and its various molecular targets is presented, which suggests that XN possesses enormous therapeutic potential against various cancers and could be potentially used as a multi-targeted anti cancer agent with minimal adverse effects.
Journal ArticleDOI

Potential of baicalein in the prevention and treatment of cancer: A scientometric analyses based review

TL;DR: Overall, this review provides a strong evidence for the potential of baicalein as a therapeutic agent for the treatment of different malignancies.
Journal ArticleDOI

Development of iPSC-based clinical trial selection platform for patients with ultrarare diseases

TL;DR: An 18-year-old patient with ultrarare Leigh-like syndrome is reported, and an induced pluripotent stem cell (iPSC)–based platform is established, and the efficacy of a panel of drugs is assessed.
Journal ArticleDOI

Embelin: A novel XIAP inhibitor for the prevention and treatment of chronic diseases.

TL;DR: In this paper, an overview of embelin, its therapeutic prospective, and the molecular targets in different chronic diseases is presented, which has shown excellent biological activities toward several chronic ailments by upregulating a number of antioxidant enzymes (e.g., SOD, CAT, GSH, etc.).